South Staffordshire Joint FormularyCannock Chase Clinical Commissioning Group East Staffordshire Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group
There is no evidence to support the use of bath and shower emollients. Patients should be advised to wash with their normal emollient as a soap substitute(but not 50:50)as this is more cost effective and provides better moisturisation. Bath emollients leave the bath very slippery and there is a risk of falling.
Please note Hydromol Cream and Ointment Preparations should be prescribed as Zeroderm
Please refer to the Supplementary ’Emollient Guide’ for more detail
NHS England has identified this product as an item that should not be routinely prescribed in primary care (Ver. 2, June 2019)
Emollient preparation with antimicrobials (Eczmol®)
Non Formulary
Emollient preparation with antimicrobials (Zerolatum® Plus)
Non Formulary
Emollin®
Non Formulary
Eucerin® Intensive
Non Formulary
Flexitol®
Non Formulary
Aquadrate 10% cream and Balneum 5% cream are equivalent preferred choices.
Hydromol® Intensive
Non Formulary
Lanolin emollient spray
Non Formulary
Oilatum®
Non Formulary
Oilatum® Plus (emollient bath additive)
Non Formulary
Oilatum® shower emollient gel
Non Formulary
Proprietary Emollient Preparations (Doublebase®)
Non Formulary
Unguentum M®
Non Formulary
Urea 5% Special Preparation
Non Formulary
Yellow Soft Parrafin BP
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)
Suitable first-line drugs for implementation in Primary Care